TY  - GEN
AU  - Morran,Douglas C
AU  - Wu,Jianmin
AU  - Jamieson,Nigel B
AU  - Mrowinska,Agata
AU  - Kalna,Gabriela
AU  - Karim,Saadia A
AU  - Au,Amy Y M
AU  - Scarlett,Christopher J
AU  - Chang,David K
AU  - Pajak,Malgorzata Z
AU  - Oien,Karin A
AU  - McKay,Colin J
AU  - Carter,C Ross
AU  - Gillen,Gerry
AU  - Champion,Sue
AU  - Pimlott,Sally L
AU  - Anderson,Kurt I
AU  - Evans,T R Jeffry
AU  - Grimmond,Sean M
AU  - Biankin,Andrew V
AU  - Sansom,Owen J
AU  - Morton,Jennifer P
TI  - Targeting mTOR dependency in pancreatic cancer
SN  - 1468-3288
PY  - 2014///0930
KW  - Animals
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - antagonists & inhibitors
KW  - Carcinoma, Pancreatic Ductal
KW  - diagnostic imaging
KW  - Cell Line, Tumor
KW  - Drug Administration Schedule
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Injections, Intraperitoneal
KW  - Mice
KW  - Mice, Mutant Strains
KW  - Mutation
KW  - PTEN Phosphohydrolase
KW  - deficiency
KW  - Pancreatic Neoplasms
KW  - Positron-Emission Tomography
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Sirolimus
KW  - TOR Serine-Threonine Kinases
KW  - Treatment Outcome
KW  - Tumor Suppressor Protein p53
N1  - Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/gutjnl-2013-306202
ER  -